six

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update

June 19, 2025 01:00 ET  | Source: Addex Therapeutics Strong cash position of CHF2.8 million at end of Q1 2025GABAB…

4 months ago

Sunrise Group Recognized 6th among ICIS 2025 Global Top 100 chemical distributors

NEW YORK, June 17, 2025 /PRNewswire/ -- Sunrise Group has once again demonstrated its industry leadership, securing a spot among…

4 months ago

Roche to advance prasinezumab into Phase III development for early-stage Parkinson’s disease

Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage…

4 months ago

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients

After a thorough clinical review, the benefit-risk for the use of Elevidys in non-ambulatory patients with Duchenne has been re-assessed,…

4 months ago

FANTASTICS from EXILE TRIBE, Former Taipei City Tourism Ambassadors, to Present BACK TO THE MEMORIES PART5 via Livestream!

Presenting a special experience to fans around the world.TOKYO--(BUSINESS WIRE)--ZAIKO will begin ticket sales on Sunday, June 15, 2025, at…

4 months ago

THE WORLD’S 50 BEST RESTAURANTS ANNOUNCES THE 51-100 LIST FOR 2025

LONDON, June 5, 2025 /PRNewswire/ -- The World's 50 Best Restaurants 2025, sponsored by S.Pellegrino & Acqua Panna, today unveils…

5 months ago

Roches Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy (SMA)

Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with SMA Evrysdi offers…

5 months ago

Blokees Initial Release Minions Mokoo Series: Minions-N-Disguise, Becomes a Banana Day Hotspot

SHANGHAI, June 3, 2025 /PRNewswire/ -- On June 1, 2025, the 2025 Minions Banana Day was officially launched in Shanghai and…

5 months ago

Roches Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancer

46% reduction in the risk of disease progression or death, and 27% reduction in the risk of death, in an…

5 months ago

Addex Convenes Annual General Meeting 2025

June 03, 2025 01:00 ET  | Source: Addex Therapeutics Geneva, Switzerland, June 3, 2025 - Addex Therapeutics (SIX: ADXN and…

5 months ago